# Afinitor

NDC: 0078-0566
Generic name: everolimus
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20090331

FDA application: NDA022334

## Active ingredients

- EVEROLIMUS: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0566"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0566
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04